Evidence map›Paper›PMID 36884299›Full record

ArticleThyroid : official journal of the American Thyroid Association2023

Large (>4 cm) Intrathyroidal Encapsulated Well-Differentiated Follicular Cell-Derived Carcinoma Without Vascular Invasion May Have Negligible Risk of Recurrence Even When Treated with Lobectomy Alone.

Ronald Ghossein, Ian Ganly, R Michael Tuttle, Bin Xu

Open access · greenAbstract read
In one paragraph

Article in Thyroid : official journal of the American Thyroid Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Guideline
  2. Aggressive follicular cell derived thyroid carcinoma: what do you need from the pathologist.Virchows Archiv : an international journal of pathology · 2026
    Review
  3. Review
  4. Article
  5. Revisiting the Relationship Between Tumor Size and Risk in Well-Differentiated Thyroid Cancer.Thyroid : official journal of the American Thyroid Association · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ronald GhosseinDepartment of Pathology and Laboratory Medicine and Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Ian GanlyDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
R Michael TuttleDivision of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Bin XuDepartment of Pathology and Laboratory Medicine and Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0003-4638-9835
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adenocarcinoma, FollicularCarcinomaGoiterThyroid NeoplasmsDisease ProgressionHumansIodine RadioisotopesRetrospective StudiesThyroidectomyIodine Radioisotopescapsular invasionminimally invasivepapillary thyroid carcinomawell-differentiated follicular cell-derived carcinoma

Identifiers

PMID36884299
PMCPMC10171951
OpenAlexW4323534191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.